Roger N. Rosenberg
About
In The Last Decade
Roger N. Rosenberg
183 papers receiving 5.6k citations
Hit Papers
Peers
Comparison fields: 5 of 150
- Molecular Biology 2.3k
- Cellular and Molecular Neuroscience 1.7k
- Physiology 1.7k
- Neurology 833
- Psychiatry and Mental health 760
Countries citing papers authored by Roger N. Rosenberg
This map shows the geographic impact of Roger N. Rosenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger N. Rosenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger N. Rosenberg more than expected).
Fields of papers citing papers by Roger N. Rosenberg
This network shows the impact of papers produced by Roger N. Rosenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger N. Rosenberg. The network helps show where Roger N. Rosenberg may publish in the future.
Co-authorship network of co-authors of Roger N. Rosenberg
This figure shows the co-authorship network connecting the top 25 collaborators of Roger N. Rosenberg. A scholar is included among the top collaborators of Roger N. Rosenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger N. Rosenberg. Roger N. Rosenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Title | Journal | Authors | Indexed citations |
|---|---|---|---|---|
| 1 | The universal brain code a genetic mechanism for memory | Journal of the Neurological Sciences | Roger N. Rosenberg | 2 |
| 2 | Active full-length DNA Aβ42 immunization in 3xTg-AD mice reduces not only amyloid deposition but also tau pathology | Alzheimer s Research & Therapy | Roger N. Rosenberg, Min Fu et al. | 34 |
| 3 | The Role of Cardiovascular Risk Factors and Stroke in Familial Alzheimer Disease | JAMA Neurology | Giuseppe Tosto, Thomas D. Bird et al. | 41 |
| 4 | Beta-amyloid auto-antibodies are reduced in Alzheimer's disease | Journal of Neuroimmunology | Bao‐Xi Qu, Yunhua Gong et al. | 42 |
| 5 | Co-stimulation with TNF receptor superfamily 4/25 antibodies enhances in-vivo expansion of CD4 + CD25 + Foxp3 + T cells (Tregs) in a mouse study for active DNA Aβ42 immunotherapy | Journal of Neuroimmunology | Doris Lambracht‐Washington, Roger N. Rosenberg | 17 |
| 6 | A noninflammatory immune response in aged DNA Aβ42-immunized mice supports its safety for possible use as immunotherapy in AD patients | Neurobiology of Aging | Doris Lambracht‐Washington, Roger N. Rosenberg | 10 |
| 7 | Anti-amyloid-beta to tau-based immunization: developments in immunotherapy for Alzheimer's disease | ImmunoTargets and Therapy | Doris Lambracht‐Washington, Roger N. Rosenberg | 29 |
| 8 | Analysis of three plasmid systems for use in DNA Aβ42 immunization as therapy for Alzheimer's disease | Vaccine | Doris Lambracht‐Washington, Min Fu et al. | 27 |
| 9 | Aβ42 gene vaccine prevents Aβ42 deposition in brain of double transgenic mice | Journal of the Neurological Sciences | Bao‐Xi Qu, Qun Xiang et al. | 45 |
| 10 | Translational Research on the Way to Effective Therapy for Alzheimer Disease | Archives of General Psychiatry | Roger N. Rosenberg | 37 |
| 11 | Platelet amyloid precursor protein processing: A bio-marker for Alzheimer's disease | Journal of the Neurological Sciences | Kun Tang, Linda S. Hynan et al. | 113 |
| 12 | Category Fluency in Mild Cognitive Impairment | Alzheimer Disease & Associated Disorders | Laura H. Lacritz, Myron Weiner et al. | 107 |
| 13 | Comparison of Alzheimer’s Disease in Native Americans and Whites | International Psychogeriatrics | Myron Weiner, Kyle Womack et al. | 17 |
| 14 | The molecular and genetic basis of neurologic and psychiatric disease | Lippincott Williams & Wilkins eBooks | Roger N. Rosenberg | 65 |
| 15 | Effects of Practice on Category Fluency in Alzheimers Disease* | The Clinical Neuropsychologist | Laura H. Lacritz, Myron Weiner et al. | 60 |
| 16 | Apoptosis and neurologic disease | The American Journal of Medicine | Lawrence S. Honig, Roger N. Rosenberg | 200 |
| 17 | Editorial Governance of the Journal of the American Medical Association | JAMA | Roger N. Rosenberg, Erica Anderson | 8 |
| 18 | Frontal lobe ataxia | Surgical Neurology | John B. Terry, Roger N. Rosenberg | 14 |
| 19 | The Prevention of Neurogenetic Disease | Archives of Neurology | Roger N. Rosenberg, Susan T. Iannaccone | 4 |
| 20 | Machado Joseph disease is not an allele of the spinocerebellar ataxia 2 locus | Human Genetics | Lindsay A. Farrer, Patrick MacLeod et al. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.